Avalyn completes enrollment in Phase 2b pulmonary fibrosis trial of AP01Aug 12Quarterly updateAvalyn Pharma Inc.pirfenidone solution
Gyre reports Q2 2026 results, advances F351 NDA and Cullgen pipelineAug 7Quarterly updateGyre Therapeutics, Inc.
Pliant's BEACON-IPF trial terminated after DSMB recommendation; results postedAug 5Trial updatePliant Therapeutics, Inc.PLN-74809
Sign inSign in